About Stem Cell
Conference Mind Globally welcomes all the researchers, scientists, scholars, professionals, engineers, exhibitors, sponsors, academic, scientific and university practitioners to attend and present their research activities virtually worldwide @ Global Stem Cell 2021 during October 06-07, 2021.
We will publish your Paper/Article worldwide in our global website scientific e-news:
Track 1. Stem Cell:
Stem cells are the body's raw materials cells from which all other cells with specialized functions are generated. Stem cells originate from two main sources: adult body tissues and embryos. Stem cells are unspecialized cells of the human body. Stem cells are special human cells that have the ability to develop into many different cell types, from muscle cells to brain cells.
Track 2. Gene Therapy:
Gene therapy is an experimental technique that uses genes to treat or prevent disease. Gene therapy is designed to introduce genetic material into cells to compensate for abnormal genes or to make a beneficial protein. Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. Human gene therapy seeks to modify or manipulate the expression of a gene or to alter the biological properties of living.
Track 3. Pluripotency:
Pluripotent cells can give rise to all of the cell types that make up the body; embryonic stem cells are considered pluripotent. Pluripotent stem cells have the ability to undergo self-renewal and to give rise to all cells of the tissues of the body. A pluripotent cel
Tracks and Key Topics
- Track 1 : Stem Cell
- Track 2 : Gene Therapy
- Track 3 : Pluripotency
- Track 4 : Genome Reprogramming:
- Track 5 : Molecular Biology
- Track 6 : Cancer Stem Cells
- Track 7 : Multipotent Stem Cells
- Track 8 : Unipotent Stem Cells
- Track 9 : Hematopoietic Stem Cells
- Track 10 : Cell & Organ Regeneration
Organizing Committee Member
The global stem cells market size generated a revenue of USD 9.38 billion in 2020. It is expected to expand at a compound annual growth rate (CAGR) of 8.8% from 2021 to 2028. The factors contributing to the growth include increasing demand for biologics, technological advancement in stem cell therapeutics, and a growing focus on the development of personalized medicines. The adult stem cells (ASCs) segment dominated the market in 2020, with a share of 85.7%. The primary factors that contributed to the dominance of the segment include the presence of minimal controversial issues concerning ethics, immune-rejection, and tumorigenesis. The application of ASCs in regenerative medicines can be further attributed to the segment growth. The ASCs bioprocessing for regenerative medicine is anticipated to face challenges during process development. The application segment can be further divided into regenerative medicine and drug discovery and development. Regenerative medicine is held the larg